Deckers steps up sales to $1.4B
[wikichart align=”center” ticker=”DECK” showannotations=”true” livequote=”true” startdate=”23-08-2011″ enddate=”23-02-2012″ width=”390″ height=”245″] Goleta-based Deckers Outdoor Corp., parent of the Ugg Australia boot brand, increased its sales 38 percent to nearly $1.4 billion in 2011 and boosted net income 25 percent $201.8 million. In an earnings release on Feb. 23, Deckers said it notched a huge boost in international Read More →
Read More →K-Swiss shares tumble on higher Q4 loss
[wikichart align=”right” ticker=”NASDAQ:KSWS” showannotations=”true” livequote=”true” startdate=”17-08-2011″ enddate=”17-02-2012″ width=”300″ height=”245″] Athletic shoe company K-Swiss stumbled into another unprofitable quarter, reporting a $25.2 million loss that came to 71 cents per share, despite higher sales. Shares of K-Swiss dropped 10.7 percent to $3.35 on Feb. 17 after the earnings announcement. In the fourth quarter of 2010, the Read More →
Read More →Higher profits in hand, region’s banks look to expand
Pacific Capital Bancorp, the largest banking company based in the Tri-Counties, turned a $70.5 million profit in 2011 after years of staggering losses. At the same time, First California Financial Group and Heritage Oaks Bancorp, the next two largest banks on the list, reported improved earnings for the year and bold plans to expand. Here’s Read More →
Read More →PCBC reports $70.5M in 2011 profits
[wikichart align=”center” ticker=”PCBC” showannotations=”true” livequote=”true” rollingdate=”6 months” width=”390″ height=”245″] Pacific Capital Bancorp, the largest bank based in the region, earned $70.5 million in 2011, its first full calendar year under the ownership of a Texas-based private equity group. The parent company of Santa Barbara Bank & Trust saw its fourth-quarter profits drop 39.8 percent to Read More →
Read More →Amgen Q4 earnings drop 8.5%
[wikichart align=”right” ticker=”NASDAQ:AMGN” showannotations=”true” livequote=”true” startdate=”26-07-2011″ enddate=”26-01-2012″ width=”300″ height=”245″] Biotech giant Amgen, which said earlier on Thursday that it would pay $1.2 billion for leukemia drugmaker Micromet, reported fourth-quarter earnings that missed analyst expectations. The Thousand Oaks-based company said fourth-quarter profits fell 8.5 percent to $934 million, or $1.08 per share, on lower sales of Read More →
Read More →